Cargando…
Risk of neutropenia among clozapine users and non-users: results from 5,847 patients
OBJECTIVE: Clozapine is underprescribed due to neutropenia risk. Blood tests every 3 months in those on continuous treatment for > 1 year who have never had an absolute neutrophil count (ANC) < 2,000/µL has been proposed as a monitoring strategy; however, there are no South American data to su...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Associação Brasileira de Psiquiatria
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827363/ https://www.ncbi.nlm.nih.gov/pubmed/34730717 http://dx.doi.org/10.1590/1516-4446-2021-1765 |